Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study

• Prif Awduron: Min-Lan Tsai (Awdur), Hsiu-Chen Lin (Awdur), Chiung-Hui Yen (Awdur), Jung-Tzu Ku (Awdur), Shian-Ying Sung (Awdur), Hsi Chang (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: MDPI AG, 2022-10-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

(1) Background: Cysteinyl leukotriene receptor antagonists (LTRAs), including montelukast and zafirlukast, are FDA-approved for treating pediatric asthma and allergic diseases. Tourette syndrome (TS), a common neuropsychiatric disorder in children, is associated with allergic diseases and asthma. In...